Find Academic Supervisors

Steven R. CaliariView profile

Associate Professor

• Biomaterials
• Mechanobiology
• Musculoskeletal Tissue Engineering
• +1 more

Steven R. Caliari is an Associate Professor in the Department of Chemical Engineering with a secondary appointment in Biomedical Engineering at the University of Virginia’s School of Engineering and Applied Science. He serves as the ChE Graduate Program Director and is a SEAS Copenhaver Fellow (2023). His research focuses on designing biomaterials to study cell-microenvironment interactions, addressing challenges in disease and tissue engineering. He holds a B.S. (2007, University of Florida), M.S. (2010), and Ph.D. (2013) in Chemical Engineering from the University of Illinois, followed by an NIH postdoctoral fellowship at the University of Pennsylvania. His research interests include biomaterials, mechanobiology, musculoskeletal tissue engineering, and advanced manufacturing for biological applications. His lab has pioneered viscoelastic hydrogel platforms and conductive collagen scaffolds, supported by NIH, NSF, DoD, and industry grants. Notable awards include the NSF CAREER Award (2021) and NIH MIRA (2020). Grants: NIH (NIGMS), NSF CAREER, V Foundation, UVA-Coulter Partnership Courses: Tissue Engineering (BME/CHE 4417), Transport Processes I (CHE 3321) Labs: Caliari Lab focuses on biomaterial design and mechanobiological studies His work bridges fundamental science and translational applications, emphasizing dynamic material systems for regenerative medicine and disease modeling.

Christopher J. CooperView profile

Professor

• Cardiovascular Medicine
• Interventional Cardiology
• Renovascular Hypertension
• +4 more

Christopher J. Cooper, M.D., is Distinguished University Professor of Medicine at the University of Toledo, Ohio, where he also served as Dean of the College of Medicine (2014-2024), CEO of University of Toledo Physicians, and Executive Vice-President for Clinical Affairs. Triple-board-certified in Internal Medicine, Cardiovascular Disease, and Interventional Cardiology, he directs the UT Clinical Coordinating Center and has led national randomized trials on renal-artery stenosis. Education & Training: B.A. magna cum laude in Biology (Philosophy minor), Wittenberg University, 1985 M.D., University of Cincinnati College of Medicine, 1988 — Valedictorian, Alpha Omega Alpha Internship & Residency, Brigham and Women’s Hospital / Harvard Medical School, 1988-1991 Cardiology Fellowship, Brigham and Women’s Hospital, 1991-1994 Harvard School of Public Health, Clinical Effectiveness Program, 1992 Research Focus: Cooper’s group investigates renovascular hypertension, renal-artery stenosis, and cell-based therapies for vascular disease. As PI of the NIH-funded CORAL trial and multiple industry grants, he has published pivotal papers defining when renal stenting benefits patients and elucidating inflammatory and signaling pathways that couple renal artery narrowing to hypertension and renal failure. Recent work integrates large-scale clinical outcomes databases with mechanistic studies on Na/K-ATPase signaling, microRNA regulation of cardiac fibrosis, and biomarkers such as CD40-ligand in renovascular disease. Honors & Awards: Best Doctors in America — multiple years (2002-2014) America’s Top Doctors, Castle Connolly — consecutive listings (2006-2015) College of Medicine Award for Excellence in Clinical Research, UT (2008) Elected Fellow, American Heart Association Council on High Blood Pressure Research (2004) Valedictorian & Alpha Omega Alpha, Univ. of Cincinnati (1988) Leadership & Grants: Cooper has held continuous NIH and industry funding for multicenter trials; he founded and directs the UT Clinical Coordinating Center, overseeing regulatory, data, and biostatistical cores for national studies. His administrative leadership spans Department Chair, Heart & Vascular Center Director, and Dean of the College of Medicine, while maintaining an active interventional cardiology practice. Laboratory & Teams: He leads the Cooper Renal & Vascular Research Group within the UT Cardiovascular Research Institute, mentoring faculty, fellows, and graduate students in translational protocols that bridge molecular cardiology, interventional imaging, and large pragmatic trials.

Kevin McHughView profile

Assistant Professor

• Biomaterials
• Biofabrication
• Drug Delivery
• +6 more

Kevin McHugh is an Assistant Professor of Bioengineering at Rice University and a CPRIT Scholar in Cancer Research. He leads the McHugh Lab, which focuses on developing biomaterial microdevices for drug delivery, cancer immunotherapy, and tissue engineering using advanced fabrication techniques like multi-photon 3D printing. His work bridges materials science, immunology, and global health, with a particular emphasis on single-injection vaccines and controlled-release systems. Education Ph.D., Biomedical Engineering, Boston University (2014) M.S., Biomedical Engineering, Boston University (2012) B.S., Biomedical Engineering, Case Western Reserve University (2009) Research Interests McHugh’s lab explores three core areas: Drug Delivery: Designing systems for targeted drug release to improve vaccine efficacy and chronic disease management. Cancer Immunotherapy: Developing localized immunostimulatory therapies to enhance anti-tumor responses. Tissue Engineering: Creating bioinstructive scaffolds for functional tissue regeneration. Recent projects include a $2M CPRIT grant for cancer immunotherapy and Gates Foundation funding to develop combination vaccines for the developing world. Grants & Awards CPRIT Scholar in Cancer Research NIH R21 Award (2024) NIH R25 Award (2024) Gates Foundation Grant (2024) Lab & Collaborations The McHugh Lab collaborates on translational research, with a focus on clinical feasibility. Notable achievements include microneedle-based vaccination record systems and heat-stable vaccine microparticles. The lab actively trains students in bioengineering, materials science, and immunology.

Haiyan ZhouView profile

Professor

• Genetic Medicine
• Nucleic Acid Therapeutics
• Rare Diseases
• +7 more

Professor Haiyan Zhou serves as Professor of Genetic Medicine at University College London (UCL), affiliated with the Institute of Child Health and Department of Genetics and Genomic Medicine. She directs the UK Platform of Nucleic Acid Therapy (UPNAT Node) for rare diseases, co-leads the Therapeutic Innovation and Trials Community Domain in Genomics England, and acts as Deputy Theme Lead for Novel Therapies at the NIHR Great Ormond Street Hospital Biomedical Research Centre. Prof. Zhou earned her MD-PhD in clinical medicine and skin pharmacology from Peking Union Medical College. Her research pioneers nucleic acid therapeutics (NAT) for rare genetic disorders, focusing on RNA-based approaches including antisense oligonucleotides, siRNA, and RNA editing for neuromuscular diseases. The Zhou Lab collaborates extensively across UCL with experts in muscular dystrophies, respiratory disorders, neurological conditions, and metabolic diseases to translate experimental therapies into clinical applications for pediatric patients. Recent publications (2023-2025) reveal a dominant focus on optimizing RNA therapeutics for spinal muscular atrophy and collagen VI-related dystrophies, with key advances in allele-specific silencing, biomarker discovery, and preclinical-to-clinical translation. Her work consistently bridges molecular mechanisms with therapeutic development, emphasizing tissue-specific delivery and treatment response monitoring. Scientific recognition includes: Harrington UK Rare Disease Scholar (2021) Lea Rose Spinal Muscular Atrophy Award (2017, 2015) Young scientist award from The SMA trust (2011) President Prize for the Young Myologist of the Year (World Muscle Society, 2006) As principal investigator, Prof. Zhou secures funding from MRC, NIHR, and the Harrington Discovery Institute for RNA therapeutic development. She mentors early-career researchers through e-COST Action, Marie Skłodowska-Curie ITN, and UCL programs while supervising MSc/PhD students. Her leadership extends to directing UCL's MSc Personalized Medicine and Novel Therapies Programme and serving on multiple education committees. The Zhou Lab operates as a multidisciplinary hub within UCL's Institute of Child Health, collaborating closely with the Dubowitz Neuromuscular Centre and international consortia like the Oligonucleotide Therapeutic Society. Current initiatives focus on individualized RNA therapy for pediatric rare diseases, with active pipelines for hereditary sensory neuropathy and COL6-related dystrophies.

• Biomedical Engineering
• Nanotechnology
• Tumor Therapy
• +4 more

Liu Hongmei is a Researcher and Master's Supervisor at Southern University of Science and Technology's Department of Biomedical Engineering. Holding a Ph.D. from the Chinese Academy of Sciences, she specializes in micro-nano robotics and tissue engineering for tumor therapy, with over 66 publications and 12 patents. Her work bridges biomedical engineering and nanotechnology for precision cancer treatments. B.S., Biological Sciences, Harbin Normal University (2005) M.S., Botany, Northeast Agricultural University (2008) Ph.D., Biochemical Engineering, Chinese Academy of Sciences (2015) Her research focuses on biomaterials engineering , nanoparticle drug delivery , and microenvironment-responsive hydrogels . Key areas include glioma therapy, traumatic brain injury recovery, and intervertebral disc degeneration treatments. Recent work explores pH/ROS/inflammation-triggered hydrogels and bioengineered bacteria for disease modulation. Article trends show a strong emphasis on nanoparticle design (2014-2025) for glioma, hydrogel development (2017-2025) for tissue repair, and biomimetic material synthesis (2023-2025) inspired by spider silk and meniscus structures. Sub-fields span pyroptosis inhibition, epigenetic reprogramming, and microbiome engineering. Jiangsu Science and Technology Award (2020) Jiangsu Medical Science and Technology Award (2020) Jiangsu Educational Science Research Award (2021) Chinese Medical Doctor Association's Outstanding Young Scientist (2018) Liu has supervised numerous projects including National Natural Science Foundation of China grants, Jiangsu Province Key R&D Program funding, and Shenzhen City General Projects. She holds 12 Chinese invention patents and collaborates with institutions like the UNESCO Centre for Higher Education Innovation.

Sheila GrantView profile

Professor

• Biomaterials
• Diagnostic Sensors/Biosensors
• Micro and Nano-Fabrication Techniques
• +5 more

Sheila Grant is a Professor in the Department of Chemical and Biomedical Engineering at the University of Missouri, affiliated with the College of Engineering. She holds leadership roles as Executive Director of Mizzou TecHub and has extensive research experience, including post-doctoral research at Lawrence Livermore National Laboratory. Her expertise spans biomaterials, diagnostic sensors, and nano-fabrication techniques. She earned her PhD, MS, and BS in Materials and Biomedical Engineering from Iowa State University. Her research focuses on advanced biomaterials for tissue engineering, nanotechnology applications in healthcare, and AI-driven materials discovery. Notable projects include a $1.87M grant for AI/ML in materials development and NSF-funded initiatives in food safety and water management. She has founded multiple high-tech ventures and holds patents in biomaterials and sensors. Grant has received prestigious awards, including Fellowships from the National Academy of Inventors, Biomedical Engineering Society, and the American Institute for Medical and Biological Engineering. Her work emphasizes interdisciplinary collaboration, bridging engineering and medicine to address global challenges in healthcare and sustainability. Grants: NSF, NIH, USDA, Army, and industrial partnerships. Labs/Teams: Mizzou TecHub, MU Materials Science & Engineering Institute. Future Work: Expanding AI-driven materials research, clinical translation of nanocomposites, and sustainable biomedical solutions.

• Exercise Physiology
• Sports Nutrition
• Genetic Polymorphisms in Athletes
• +6 more

Patrizia Proia is an Associate Professor at the University of Palermo, Department of Psychological, Pedagogical, Physical Exercise and Training Sciences. Her research focuses on exercise physiology, sports genetics, and neurobiological mechanisms linked to physical activity. She teaches courses in biochemistry, physiology of nutrition, and sports training adaptation. Current research on microbiome-exercise interactions Developing protocols for MS and Parkinson's rehabilitation Investigating genetic polymorphisms in elite athletes Exploring nutrigenomics and functional foods Recent publications analyze: Muscle regeneration through probiotic supplementation Impact of nanotechnological devices on pain management Epigenetic regulation of executive functions Bone health in gymnasts and cancer patients Role of gut microbiome in exercise response

• Glaucoma
• Cataract Surgery
• Micro-Invasive Glaucoma Surgery (MIGS)
• +4 more

Paul Harasymowycz is a Clinical Associate Professor in the Department of Ophthalmology at the Faculty of Medicine, Université de Montréal. His clinical and research focus spans glaucoma, cataract surgery, and micro-invasive glaucoma surgery (MIGS), with expertise in eye imaging and telemedicine applications. He is affiliated with the CIUSSS de l'Est-de-l'Île-de-Montréal (Hôpital Maisonneuve-Rosemont) and serves as Medical Director of the Fondation de Glaucome du Québec. Education: Loyola High School (1983-1988), Marianopolis College (Health Sciences, 1990), McGill University (MDCM, 1995), Residency in Ophthalmology at Université de Montréal (1996-2000), Fellowship in Glaucoma at Wills Eye Hospital (2000-2001), MSc in Clinical Research (2001-2006). His research explores innovative surgical techniques and telemedicine for glaucoma screening, particularly in high-risk populations. He has co-authored key studies comparing MIGS devices (e.g., Hydrus vs. iStent) and analyzed long-term outcomes of trabecular microbypass stents. He has received multiple professional certifications and is a member of the ASCRS Glaucoma Clinical Committee. Scientific contributions include peer-reviewed articles on MIGS efficacy, imaging technologies, and telemedicine. He has mentored students such as Roman Meda (MSc, 2015) and Alvine Kamdeu Fansi (PhD, 2010), and is involved in international collaborations, including Haiti glaucoma screening initiatives and a Canada-Brazil research mission.

• Bioengineering
• Biomaterials
• Tissue Engineering
• +10 more

Devid Maniglio is an Associate Professor at the Department of Industrial Engineering, University of Trento. His research focuses on bioengineering, biomaterials, and tissue engineering, with a particular emphasis on bioprinting, surface modification, and functional materials. He has contributed to advancements in silk fibroin and hydrogel-based systems for medical applications. Research Interests Bioengineering for personalized medicine Biomaterials and surface engineering 3D bioprinting and tissue regeneration Molecular imprinting and biosensors Drug delivery and cell encapsulation Teaching Diagnostic and therapeutic technologies for personalized medicine Engineered materials for precision medicine Fundamentals of biomedical technologies Functional surfaces laboratory Labs & Collaborations Devid Maniglio is affiliated with the Functional Surfaces Laboratory at the University of Trento, collaborating with researchers such as Stefano Rossi and Flavio Deflorian. His work integrates interdisciplinary approaches in biomedical engineering and sustainable medical technologies.

Donald T DonovanView profile

Professor

• Otolaryngology
• Head and Neck Surgery
• Thyroid Disorders
• +3 more

Dr. Donald T Donovan is a full-time Professor and Chair of the Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery at Baylor College of Medicine . He serves as Chief of Service at Ben Taub General Hospital (BSLMC) and specializes in clinical care for thyroid disorders, head and neck tumors, laryngeal/voice disorders, and endoscopic sinus surgery. Education : MD from Baylor College of Medicine (1976) Training : Otolaryngology Residency at Baylor College of Medicine (1976); Head and Neck Surgery Fellowship at Columbia University Affiliate Hospitals (1981) His research focuses on thyroid cancer , tracheal stenosis , and endoscopic techniques for upper aerodigestive tract disorders. Recent publications highlight innovations in surgical navigation, collagen vocal cord augmentation, and endoscopic management of Zenker's diverticulum. Award highlights: That's the Way Award (2016) for compassionate patient care

VOLKAN KILINÇOĞLUView profile

Professor

• Orthopedic Surgery
• Traumatology
• Pediatric Orthopedics
• +4 more

Professor Volkan Kilinçoğlu is a faculty member at Gaziantep University Faculty of Medicine, Department of Surgical Medical Sciences, specializing in Orthopedics and Traumatology. He holds the academic rank of Professor since 2017, following his tenure as Assistant Professor at Kahramanmaraş Sutçu İmam University (2015-2017). Education: Medical Specialization (2002-2006): Istanbul Medeniyet University, Faculty of Medicine, Department of Orthopedics and Traumatology Licence (1995-2001): Istanbul University, Cerrahpaşa Faculty of Medicine His research spans orthopedic trauma , pediatric orthopedics , and fracture management , with significant contributions to femoral neck fractures, tibial injuries, and pediatric elbow trauma. He emphasizes innovative surgical techniques and outcomes-based analysis , frequently utilizing advanced imaging and biomaterials to optimize patient recovery in complex cases. Analysis of his 51 publications reveals evolving expertise from traditional trauma management toward precision orthopedics . Recent work (2021-2023) prioritizes 3D CT fracture mapping, minimally invasive pediatric fixation, and quality-of-life metrics in spinal/hip procedures, reflecting integration of technology with patient-centered care. Supervision and Grants: Professor Kilinçoğlu has mentored 5 medical specialization theses and led two national research projects: "Comparison of PRP, Dry Needling, and Corticosteroid Efficacy in Plantar Fasciitis Treatment" (2021-2022) and "Fracture Mapping of Adult Femoral Neck Fractures with 3D CT" (2022). His clinical teaching covers congenital anomalies, cerebral palsy, and musculoskeletal trauma.

Hasan Basri ArifoğluView profile

Associate Professor

• Medical Retina
• Vitreoretinal Surgery
• Ophthalmology
• +3 more

Prof. Dr. Hasan Basri Arifoğlu is an Associate Professor at Okan University Faculty of Medicine, Department of Ophthalmology, specializing in Medical Retina and Vitreoretinal Surgery. He has been actively contributing to ophthalmology research and clinical practice since completing his specialist training in 2010. Graduated from Erciyes University Faculty of Medicine Completed specialist training at SB Ankara Atatürk Training and Research Hospital (2010) Completed compulsory service at Ulucanlar Eye Training and Research Hospital and Rize Kaçkar State Hospital Participated in preceptorship program at University of Chicago Vitreoretinal Surgery Unit (2015) Attended EVRS fellowship course in Bremen (2016) Appointed Associate Professor at Okan University Faculty of Medicine (2017) Dr. Arifoğlu's research primarily focuses on Medical Retina and Vitreoretinal Surgery, with significant contributions to understanding retinal diseases, vitreoretinal surgical techniques, and ocular imaging. His work explores the relationship between systemic conditions and ocular manifestations, particularly in areas such as choroidal thickness changes, diabetic retinopathy, and age-related macular degeneration. He has pioneered research on the effects of physiological maneuvers like Valsalva on ocular structures and has contributed to advancements in corneal crosslinking techniques for pediatric keratoconus. His extensive publication record demonstrates expertise across multiple ophthalmological subspecialties, with particular emphasis on retinal vascular diseases, macular disorders, and innovative surgical approaches. Dr. Arifoğlu has published over 25 articles in international refereed journals and presented at numerous international conferences, accumulating 99 citations according to Web of Science and Google Scholar. Gazi Eye Foundation Scientific Incentive Award (2014) EVRS European Vitreoretinal Training School Certification (2016) Dr. Arifoğlu has been actively involved in numerous research collaborations and has supervised multiple studies examining the relationship between systemic diseases and ocular manifestations. His work often involves multidisciplinary approaches, collaborating with cardiology, hematology, and obstetrics specialists to understand how systemic conditions affect ocular structures. He has been instrumental in establishing protocols for evaluating choroidal thickness changes in various clinical scenarios and has contributed to refining vitreoretinal surgical techniques. Through his affiliation with Okan University Hospital, Dr. Arifoğlu leads a research team focused on advancing vitreoretinal diagnostics and therapeutics. His laboratory utilizes state-of-the-art imaging technologies including spectral-domain optical coherence tomography to investigate retinal and choroidal pathologies. The team is currently exploring innovative approaches to managing macular edema and optimizing outcomes for patients with retinal vascular diseases.

• Radiation Biology
• Medical Physics
• Dosimetry
• +12 more

Professor Giuseppe Schettino is a Professor of Medical Physics at the University of Surrey with a joint appointment at the National Physical Laboratory (NPL). He also holds honorary positions as Senior Lecturer at Queen’s University Belfast and University College London. His academic journey began with a degree in Nuclear Physics from the University of Naples (1994) and a PhD from King’s College London (1999), followed by postdoctoral work at the Gray Cancer Institute and Columbia University. He served as a Lecturer at Queen’s University Belfast (2007–2013) before joining NPL as Principal Research Scientist (2013–2018), where he later became Head of Science for Medical Physics. Education: PhD in Physics, King’s College London, UK (1999) Laurea in Nuclear Physics, University of Naples, Italy (1994) His research focuses on radiation biology, advanced radiotherapy, and dosimetry , with emphasis on MRI-guided radiotherapy, proton and ion beam therapy, microdosimetry, and nanoparticle-based radiosensitization. He leads UK efforts in standardizing dosimetry and QA for preclinical radiotherapy, funded by Innovate UK and supported by CTRad and Cancer Research UK. His recent publications (2020–2023) reflect a strong trend in preclinical radiotherapy, 3D tumour models, dosimetry innovation, and biological effects of radiation . Key themes include radiomics, magnetic field interactions, and nanoparticle applications in cancer therapy. Scientific Awards and Recognition: No explicitly listed awards, but leadership in nationally funded programs indicates recognition. He has advised and collaborated with numerous researchers across institutions. Though no formal student list is provided, his senior authorship on multiple studies suggests mentorship roles. He is actively involved in developing anthropomorphic phantoms, end-to-end QA tests, and novel detectors for preclinical research. Labs and Teams: Medical Radiation Group, National Physical Laboratory Collaborations with Queen’s University Belfast, UCL, and international radiobiology consortia Lead of UK standardization initiatives in preclinical dosimetry

• Bioplastics
• Sustainable Packaging
• Controlled Release Matrices
• +4 more

Mercedes Jimenez Rosado is a Professor at the University of León within the Department of Applied Chemistry and Physics, affiliated with the Faculty of Biological and Environmental Sciences and the IQUIMAB research group focused on Chemical, Environmental, and Bioprocess Engineering. PhD in Food Science and Technology from the University of Seville (2022), with thesis on "Development of soy protein matrices with the incorporation of micronutrients for use in horticulture" Supervised by Dr. Antonio Guerrero Conejo and Dr. Alberto Romero García Her research spans bioplastics, controlled release systems, and sustainable material development for both agricultural and biomedical applications. She specializes in protein-based matrices incorporating micronutrients (iron, zinc) for horticultural use, biodegradable packaging from agro-food waste, and biomedical scaffolds using collagen/chitosan hybrids with nanoparticle modifications. Recent publications demonstrate expertise in reactive extrusion, crosslinking techniques, and characterization of mechanical properties across diverse protein sources (soy, pea, gluten). She explores dual-use applications like magnetic hyperthermia and drug delivery systems, while maintaining focus on eco-friendly synthesis methods and educational innovations in sustainable technologies. Contact: mjimr@unileon.es

David Andrew BrownView profile

Associate Professor

• Limb Regeneration
• Digit Regeneration
• Wound Healing
• +4 more

David A. Brown, M.D., Ph.D. is Associate Professor of Surgery and Vice Chief of Research at Duke University in the Division of Plastic, Maxillofacial, and Oral Surgery. He serves as Medical Director of the Duke Wound Healing Clinic and Co-Director of the Duke Regeneration Center. His academic journey began with a B.S. in engineering from University of Colorado (1999), followed by a Ph.D. in biomedical engineering at UCLA (2008), M.D. from UC Irvine (2009), and surgical training at University of Washington Medical Center (2009-2014) and Duke University (2014-2017). Research Interests Dr. Brown's work focuses on limb and digit regeneration , targeted muscle reinnervation , and advanced wound healing . His research bridges regenerative medicine , biomedical engineering , and clinical plastic surgery to develop novel therapies for complex surgical wounds and tissue defects. Recent studies analyze cellular mechanisms in hidradenitis suppurativa , biodegradable scaffold applications , and photothermal cancer ablation using nanotechnology. Publications & Grants His 15 most recent publications span topics from prophylactic muscle flap techniques to computational analysis of cleft lip deformities . Current grants include National Institutes of Health funding (2024-2029) for Enhancing limb regeneration with gene therapy and multiple The Plastic Surgery Foundation awards. Fellow of the American College of Surgeons Board-certified in Surgery, Plastic Surgery, and Wound Management ASCI PSSF Fellowship recipient Clinical Leadership As Vice Chief of Research (2023-present) and Medical Director of Duke Wound Clinic, he directs regenerative medicine initiatives and advanced wound care programs at Duke University Medical Center.